Get started
Author

Shilpa Johri

Observed names: S Johri, S. Johri, SHILPA JOHRI
ORCID: 0000-0002-7705-0984
Observed ORCID: 0000-0002-7705-0984
OpenAlex ID: A5002853980
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
2021 · Marius M Hoeper, Hikmet Al-Hiti, et al. · The Lancet Respiratory Medicine · 159
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
2021 · Steven D Nathan, Aaron Waxman, et al. · The Lancet Respiratory Medicine · 153
BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
2022 · Leslie A. Spikes, Abubakr A. Bajwa, et al. · Pulmonary Circulation · 40
Steatosis–lactic acidosis syndrome associated with stavudine and lamivudine therapy
2000 · Shilpa Johri, Samer Alkhuja, et al. · AIDS · 35
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
2023 · Steven D Nathan, Shilpa Johri, et al. · Thorax · 25
PDF
Anaphylaxis From Intravenous Thiamine-long Forgotten?
2000 · Shilpa Johri, Smitha Shetty, et al. · The American Journal of Emergency Medicine · 23
Bilateral Pneumothoraces After Unilateral Transthoracic Needle Biopsy of a Lung Nodule
2003 · Shilpa Johri, David Berlin, et al. · CHEST Journal · 15
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
2023 · Connie N. Hess, Judith Hsia, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 12
PDF
Cardiopulmonary arrest secondary to haloperidol
2000 · Shilpa Johri, Hammad Rashid, et al. · The American Journal of Emergency Medicine · 12
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension
2025 · Sandeep Sahay, Harold Palevsky, et al. · Respiratory Medicine · 5
PDF
Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial
2026 · Toby M Maher, Mark J Hamblin, et al. · American Journal of Respiratory and Critical Care Medicine · 4
Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension
2022 · S Nathan, R Argula, et al. · 13.01 - Pulmonary hypertension · 4
A 61-Year-Old Woman With Exertional Dyspnea and Right-Sided Heart Enlargement
2011 · Shilpa Johri, Gan H. Dunnington · CHEST Journal · 3
A Novel BMPR2 Mutation Associated with Pulmonary Arterial Hypertension in an Octogenarian
2010 · Shilpa Johri, Gan H. Dunnington, et al. · Lung · 3
PDF
Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension
2021 · Steven D. Nathan, Aaron Waxman, et al. · SSRN Electronic Journal · 2
Objective clinical scoring system and diagnostic variability in idiopathic pulmonary fibrosis
2026 · Charlotte Abecassis, Jean Pastre, et al. · BMC Pulmonary Medicine
Long-term Outcomes and Dosing in the Breeze Study Optional Extension Phase
2024 · LESLIE A SPIKES, ABUBAKR A BAJWA, et al. · CHEST Journal
Evaluation of the Contribution of Clinical Parameters for the Diagnosis of Idiopathic Pulmonary Fibrosis by an International Panel of Clinicians
2024 · C. Abecassis, J. Pastre, et al.
Abstract 113: Novel Tissue Factor Inhibition For Thromboprophylaxis In COVID-19: Primary Results Of The ASPEN-COVID-19 Phase 2b Randomized Trial
2022 · Connie N Hess, Mark R Nehler, et al. · Arteriosclerosis Thrombosis and Vascular Biology
Works count: 19
Citation count: 493
H-index: 9
I10-index: 9
Year
Topic
Type